MedMitra AI, a pioneering Health-Tech platform, has secured 3 crore INR in a Pre-Seed funding round. The round was co-led by leading venture capital firms All In Capital and WEH Ventures, alongside angel investors Dr. Rohan Khandelwal, Pawan Gupta, and Venkat Subramanyam. This funding marks a significant step in MedMitra AI’s journey to reshape healthcare delivery through advanced AI technology.
MedMitra AI is at the forefront of innovation, developing autonomous AI agents tailored to assist healthcare professionals in diagnosis, treatment, and prognosis. By integrating and analysing multimodal inputs—including patient medical history, lab reports, existing prescriptions, and advanced imaging—the platform empowers doctors to deliver precise, efficient, and personalised care. With an initial focus on General Medicine and its super-specialties for diagnosis, and chronic care for treatment and prognosis – MedMitra AI aims to enhance clinical outcomes while optimising time and resource efficiency within the healthcare system.
Shivangi Sharma, Co- founder, MedMitra AI, who holds a Master’s degree in AI from North-western University, added, “Our mission is to create innovative, AI-driven solutions that doctors can trust and integrate seamlessly into their daily workflows. By prioritizing intuitive design, reliability, and clinical relevance, we aim to build a product that becomes indispensable for every doctor across the country.”
The idea for MedMitra AI was inspired by the everyday challenges co-founder Dr. Anushka Sharma faced as a practicing physician. For both Dr. Sharma and her fellow co-founder, Shivangi Sharma—who hails from a family of doctors—this venture is deeply personal.
“This investment fuels our ambition to redefine healthcare by equipping doctors with AI tools that address real-world challenges. At MedMitra AI, our goal is to empower clinicians with actionable insights, bridging the gap between complex medical data and patient care. By doing so, we make healthcare delivery faster and aid our country’s overburdened doctors,” said Dr. Anushka Sharma, Co-Founder, MedMitra AI.
The newly secured funding will primarily be used to expand MedMitra AI’s team of experts, accelerate the development of its AI-powered solutions, and strengthen its market presence across existing and new regions. The team also plans to release a specialised version of the platform for medical students that will help accelerate learning, enhance medical education, and better prepare students for the challenges they will face in clinical practice.
Kushal Bhagia, Founder at All In Capital stated– “We are proud to support Shivangi and Anushka in their vision to revolutionise doctor-patient interaction. MedMitra AI is designed to alleviate doctors’ heavy workload by streamlining the diagnostic process, enabling them to deliver faster and more accurate outcomes. Moreover, the platform ensures a consistent, high-quality patient experience extending beyond metropolitan areas to smaller cities and underserved communities. This combination of innovation and inclusivity makes MedMitra AI a true game-changer in the healthcare landscape.”
Speaking on the investment, Rohit Krishna, GP at WEH Ventures, stated, “For far too long, the Indian health-tech ecosystem has prioritized hospitals and patients, often neglecting the pivotal role of doctors. When we engaged with doctors in Jaipur using MedMitra, their excitement and vision for how the product could evolve
were truly inspiring. What stood out even more was their willingness to pay a monthly subscription fee without hesitation—a clear testament to the product’s value. That’s when we knew we had to invest. This marks our first step into Vertical AI, and we are excited about the transformative potential MedMitra brings to healthcare.”
The platform will assist healthcare professionals in diagnosing, treating, and predicting medical conditions with greater accuracy and efficiency, ultimately improving the overall quality of care.
The AI in healthcare market in India is expected to reach a projected revenue of $8.73 billion by 2030, with a compound annual growth rate of 41.8% from 2024 to 2030. This remarkable growth is driven by increased healthcare expenditure, technological advancements, and supportive government initiatives such as the India AI Mission, fostering innovation and deep-tech start-ups in the healthcare domain.
Speaking on the funding, Dr.Rohan Khandelwal stated – “It’s an absolute pleasure to collaborate with the MedMitra team. This is a pivotal moment for AI to transform clinical practice in India, and the innovative product developed by the MedMitra team holds immense potential.”
With this strategic funding and unwavering commitment to innovation, MedMitra AI is poised to spearhead a new era of AI-driven healthcare. Its ambitious roadmap ensures the company stays at the forefront of global health-tech advancements, enhancing patient care, streamlining access to medical histories, and revolutionising how diagnoses and treatments are approached.